STEAP4 is a transmembrane protein that belongs to the STEAP family and is primarily expressed in the prostate, liver, and several other tissues. It also plays an important role in transport and signaling across the cell membrane. The expression of STEAP4 is associated with certain cancers, such as prostate cancer and liver cancer, making it a subject of research as a potential biomarker and therapeutic target, particularly in the development of targeted therapies and immunotherapies for these cancers.
Genomeditech provides resources related to the STEAP4 target, including overexpression cell lines, which can support the in vitro activity validation of STEAP4-targeting antibodies. These tools will assist researchers in better evaluating and optimizing the development of STEAP4-related drugs, advancing their application in tumor immunotherapy.
